CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Class A Common Stock	Class B Common Stock	Common Stock Class A Common Stock	Common Stock Class B Common Stock	Additional Paid-In Capital	Accumulated Deficit
Balance at beginning of the period (in shares) at Dec. 31, 2023				181,221,794	26,426,937
Balance at beginning of the period at Dec. 31, 2023	$ 220,053			$ 18	$ 3	$ 949,670	$ (729,638)
Increase (Decrease) in Stockholders' Equity
Net loss	(37,467)						(37,467)
Common stock issued upon vesting of restricted stock units, net (in shares)				4,815,903
Common stock issued upon vesting of restricted stock units, net	1			$ 1
Stock-based compensation expense	11,693					11,693
Balance at end of the period (in shares) at Jun. 30, 2024				186,037,697	26,426,937
Balance at end of the period at Jun. 30, 2024	194,280			$ 19	$ 3	961,363	(767,105)
Balance at beginning of the period (in shares) at Mar. 31, 2024				184,214,377	26,426,937
Balance at beginning of the period at Mar. 31, 2024	204,004			$ 18	$ 3	955,382	(751,399)
Increase (Decrease) in Stockholders' Equity
Net loss	(15,706)						(15,706)
Common stock issued upon vesting of restricted stock units, net (in shares)				1,823,320
Common stock issued upon vesting of restricted stock units, net	1			$ 1
Stock-based compensation expense	5,981					5,981
Balance at end of the period (in shares) at Jun. 30, 2024				186,037,697	26,426,937
Balance at end of the period at Jun. 30, 2024	194,280			$ 19	$ 3	961,363	(767,105)
Balance at beginning of the period (in shares) at Dec. 31, 2024		188,626,154	26,426,937	188,626,154	26,426,937
Balance at beginning of the period at Dec. 31, 2024	168,832			$ 19	$ 3	970,940	(802,130)
Increase (Decrease) in Stockholders' Equity
Net loss	(27,801)						(27,801)
Net proceeds from share offering (in shares)				27,600,000
Net proceeds from share offering	$ 81,006			$ 3		81,003
Common stock issued upon exercise of stock options (in shares)	179,503			179,503
Common stock issued upon exercise of stock options	$ 274					274
Common stock issued upon vesting of restricted stock units, net (in shares)				7,077,422
Common stock issued upon vesting of restricted stock units, net	(2,775)					(2,775)
Common stock issued for employee stock purchase plan (in shares)				1,126,754
Common stock issued for employee stock purchase plan	949					949
Stock-based compensation expense	12,321					12,321
Balance at end of the period (in shares) at Jun. 30, 2025		224,609,833	26,426,937	224,609,833	26,426,937
Balance at end of the period at Jun. 30, 2025	232,806			$ 22	$ 3	1,062,712	(829,931)
Balance at beginning of the period (in shares) at Mar. 31, 2025				220,818,648	26,426,937
Balance at beginning of the period at Mar. 31, 2025	239,696			$ 22	$ 3	1,055,768	(816,097)
Increase (Decrease) in Stockholders' Equity
Net loss	(13,834)						(13,834)
Net proceeds from share offering	(104)					(104)
Common stock issued upon exercise of stock options (in shares)				99,676
Common stock issued upon exercise of stock options	142					142
Common stock issued upon vesting of restricted stock units, net (in shares)				2,564,755
Common stock issued for employee stock purchase plan (in shares)				1,126,754
Common stock issued for employee stock purchase plan	949					949
Stock-based compensation expense	5,957					5,957
Balance at end of the period (in shares) at Jun. 30, 2025		224,609,833	26,426,937	224,609,833	26,426,937
Balance at end of the period at Jun. 30, 2025	$ 232,806			$ 22	$ 3	$ 1,062,712	$ (829,931)